Movement patterns of the European lobster Homarus gammarus : investigating the effects of habitat use and behaviour patterns on catchability

PhD ThesisCatch per unit effort (CPUE) is an index of abundance used in fisheries stock assessments. CPUE is typically calculated using fishery data and standardised using statistical methods. A major assumption of fisheries stock assessments is that all individuals are equally available to the fishery, neglecting the possibility that individual-level variability in physical traits, internal states, and expressed behaviour will likely change over time, affecting the probability of capture. However, many knowledge gaps exist regarding behaviour of free-ranging species. This study used fine-scale acoustic telemetry data to quantify free-ranging behaviour of the commercially important European lobster to improve uncertainty surrounding estimates of catch. Behaviour in the vicinity of traps was quantified using an experimental approach that highlighted the highly variable response rate at which lobsters approach traps, and the importance of field studies to capture the full range of movements when compared to mesocosm studies. The interaction between animals at traps is an important aspect of catch, but space-sharing and interaction between free-ranging lobsters has not previously been quantified. A hierarchical approach was used to assess space-sharing, contact rates, and fine-scale interaction between lobsters of the same, and opposite sex. Some lobsters interacted with multiple individuals, commonly on shelter providing substrate; space-sharing and interaction was likely driven by more mobile males. Trap exposure has previously been correlated with increased movement, but the fine-scale drivers of movement, and behavioural states relating to movement, have not been identified. Different aspects of lobster movement were investigated and drivers of movement varied by individual. Interpretation of results varied with the sampling period highlighting the importance of correctly matching the resolution of the behaviour to that of the data collection. Finally an individual-based model was used to demonstrate how movement and behaviour of lobsters can affect catch, to allow better informed sustainable management practice

Crossing the divide from education to employment - do business students see group work as a useful bridge?

This study explores students’ perceptions of the connections between undergraduate group work and employment and considers if it can act as a supportive bridge between the two. Recent graduates were able to see group work as a ‘bridging tool’ as they had developed a skillset that provided stability when dealing with unfamiliar workplace situations. Current students could conceive of group work as providing ‘employability currency’ for applications and to secure an interview, but few could extrapolate this to the workplace. Implications for practice include the development of initiatives to raise the awareness and importance of both positive and negative group work and consistently highlighting its functionality as an important bridging tool

Positioning Children’s Voice in Clinical Trials Research: A New Model for Planning, Collaboration, and Reflection

Following the United Nations Convention on the Rights of the Child, there has been considerable growth in research with children about health and services that affect them. Creative methods to engage with children have also been developed. One area where progress has been slower is the inclusion of children’s perspectives in qualitative research in the context of clinical trials or feasibility studies. Addressing this gap, this article discusses experiences of, and reflections on, the process of researching children’s views as part of a clinical feasibility study. The article considers what worked well and highlights remaining dilemmas. A new continuum of children’s engagement in research is presented, designed to assist researchers to make explicit the contingent demands on their research, and to suggest a range of techniques from within the broader fields of health, childhood studies, and education research that could be used to forward qualitative research in clinical contexts

Budgeting Basics for New Academic Chairpersons

The session is geared to new chairpersons who have little or no experience with budgets. Emphases will be placed on working with the dean to create fiscal flexibility and to incentivize budget expansion

Selecting plant traits for soil erosion control in grassed waterways under a changing climate: A growth room study

Grassed waterways are used to mitigate the offsite transport of sediment generated by soil erosion. This study used a novel trait‐based ranking approach as a method to screen potential candidate grass monocultures and mixes based on their theoretical performance in reducing (1) detachment via rainsplash, (2) detachment via scouring due to concentrated flow and (3) sediment transport and deposition processes. Selected grass species were grown under simulated UK summer and autumn establishment conditions under three different replicated rainfall scenarios: drought, normal rainfall and excess rainfall. The grass species used were the novel hybrid species Festulolium cv Prior (Fest_1), Festulolium Bx511 (Fest_2) and a conventional mixture of Lolium perenne and Festuca rubra (Conv). Monocultures and mixtures of these species were studied. Plant traits pertinent to control of soil erosion by water were measured. Above ground traits included plant height, percentage ground cover, above ground biomass, stem diameter, stem area density and number of tillers. Below ground traits included total root length, root total surface area, below ground biomass, root diameter and % fine roots ≤0.25 mm. For summer conditions, the species treatments which had the highest overall soil erosion mitigation potential were Conv, Fest_1 + 2 + Conv and Fest_2. For autumn conditions, the best treatments were Fest_1 + 2, Fest_1 + 2 + Conv and Conv. The Fest 1 + 2 + conv had more desirable traits for erosion control than mono Festulolium treatments for the autumn conditions. The conventional mixture had more desirable traits for erosion control than mono Festulolium treatments in both climate scenarios. The results indicate that the trait‐based ranking approach utilised in this study can be used to inform rapid screening of candidate grass species for soil erosion control

Monoclonal Antibodies to Distinct Regions of Human Myelin Proteolipid Protein Simultaneously Recognize Central Nervous System Myelin and Neurons of Many Vertebrate Species

Myelin proteolipid protein (PLP), the major protein of mammalian CNS myelin, is a member of the proteolipid gene family (pgf). It is an evolutionarily conserved polytopic integral membrane protein and a potential autoantigen in multiple sclerosis (MS). To analyze antibody recognition of PLP epitopes in situ, monoclonal antibodies (mAbs) specific for different regions of human PLP (50–69, 100–123, 139–151, 178–191, 200–219, 264–276) were generated and used to immunostain CNS tissues of representative vertebrates. mAbs to each region recognized whole human PLP on Western blots; the anti-100–123 mAb did not recognize DM-20, the PLP isoform that lacks residues 116–150. All of the mAbs stained fixed, permeabilized oligodendrocytes and mammalian and avian CNS tissue myelin. Most of the mAbs also stained amphibian, teleost, and elasmobranch CNS myelin despite greater diversity of their pgf myelin protein sequences. Myelin staining was observed when there was at least 40% identity of the mAb epitope and known pgf myelin proteins of the same or related species. The pgf myelin proteins of teleosts and elasmobranchs lack 116–150; the anti-100–123 mAb did not stain their myelin. In addition to myelin, the anti-178– 191 mAb stained many neurons in all species; other mAbs stained distinct neuron subpopulations in different species. Neuronal staining was observed when there was at least approximately 30% identity of the PLP mAb epitope and known pgf neuronal proteins of the same or related species. Thus, anti-human PLP epitope mAbs simultaneously recognize CNS myelin and neurons even without extensive sequence identity. Widespread anti-PLP mAb recognition of neurons suggests a novel potential pathophysiologic mechanism in MS patients, i.e., that anti-PLP antibodies associated with demyelination might simultaneously recognize pgf epitopes in neurons, thereby affecting their functions

Comparative analysis of the Potter Tower and a new Track Sprayer for the application of residual sprays in the laboratory

Background: Efforts to evaluate the residual efficacy of new indoor residual spraying (IRS) formulations have identified limitations with the industry standard laboratory sprayer, the Potter Spray Tower (PT). Calibrating the PT can be time-consuming, and the dosing of surfaces may not be as accurate or uniform as previously assumed. Methods: To address these limitations, the Micron Horizontal Track Sprayer with Spray Cabinet (TS) was developed to provide higher efficiency, ease of operation and deposition uniformity equal to or better than the PT. A series of studies were performed using a fluorescent tracer and three IRS formulations (Actellic® 300CS, K-Othrine WG250 and Suspend PolyZone) sprayed onto surfaces using either the PT or the TS. Results: Deposition volumes could be accurately calibrated for both spray systems. However, the uniformity of spray deposits was higher for the TS compared to the PT. Less than 12% of the volume sprayed using the PT reaches the target surface, with the remaining 88% unaccounted for, presumably vented out of the fume hood or coating the internal surfaces of the tower. In contrast, the TS deposits most of the spray on the floor of the spray chamber, with the rest contained therein. The total sprayed surface area in one run of the TS is 1.2 m2, and the operational zone for spray target placement is 0.7 m2, meaning that 58% of the applied volume deposits onto the targets. The TS can treat multiple surfaces (18 standard 15 × 15 cm tiles) in a single application, whereas the PT treats one surface at a time and a maximum area of around 0.0225 m2. An assessment of the time taken to perform spraying, including the setup, calibration and cleaning, showed that the cost of application using the TS was around 25–35 × less per tile sprayed. Standard operating procedures (SOPs) for calibration and use of both the Potter Tower and Track Sprayer have been developed. Conclusions: Overall, the TS represents a significant improvement over the PT in terms of the efficiency and accuracy of IRS formulation applications onto test substrates and offers a useful additional tool for researchers and manufacturers wanting to screen new active ingredients or evaluate the efficacy of IRS or other sprayable formulations for insect control

Cannabidiol for the treatment of cannabis use disorder:a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial

This is the author accepted manuscript. The final version is available from Elsevier via the DOI in this recordData sharing: We are unable to share data because participants did not provide consent for data sharing.Background A substantial and unmet clinical need exists for pharmacological treatment of cannabis use disorders. Cannabidiol could offer a novel treatment, but it is unclear which doses might be efficacious or safe. Therefore, we aimed to identify efficacious doses and eliminate inefficacious doses in a phase 2a trial using an adaptive Bayesian design. Methods We did a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial at the Clinical Psychopharmacology Unit (University College London, London, UK). We used an adaptive Bayesian dose-finding design to identify efficacious or inefficacious doses at a-priori interim and final analysis stages. Participants meeting cannabis use disorder criteria from DSM-5 were randomly assigned (1:1:1:1) in the first stage of the trial to 4-week treatment with three different doses of oral cannabidiol (200 mg, 400 mg, or 800 mg) or with matched placebo during a cessation attempt by use of a double-blinded block randomisation sequence. All participants received a brief psychological intervention of motivational interviewing. For the second stage of the trial, new participants were randomly assigned to placebo or doses deemed efficacious in the interim analysis. The primary objective was to identify the most efficacious dose of cannabidiol for reducing cannabis use. The primary endpoints were lower urinary 11-nor-9-carboxy-δ-9-tetrahydrocannabinol (THC-COOH):creatinine ratio, increased days per week with abstinence from cannabis during treatment, or both, evidenced by posterior probabilities that cannabidiol is better than placebo exceeding 0·9. All analyses were done on an intention-to-treat basis. This trial is registered with ClinicalTrials.gov (NCT02044809) and the EU Clinical Trials Register (2013-000361-36). Findings Between May 28, 2014, and Aug 12, 2015 (first stage), 48 participants were randomly assigned to placebo (n=12) and to cannabidiol 200 mg (n=12), 400 mg (n=12), and 800 mg (n=12). At interim analysis, cannabidiol 200 mg was eliminated from the trial as an inefficacious dose. Between May 24, 2016, and Jan 12, 2017 (second stage), randomisation continued and an additional 34 participants were allocated (1:1:1) to cannabidiol 400 mg (n=12), cannabidiol 800 mg (n=11), and placebo (n=11). At final analysis, cannabidiol 400 mg and 800 mg exceeded primary endpoint criteria (0·9) for both primary outcomes. For urinary THC-COOH:creatinine ratio, the probability of being the most efficacious dose compared with placebo given the observed data was 0·9995 for cannabidiol 400 mg and 0·9965 for cannabidiol 800 mg. For days with abstinence from cannabis, the probability of being the most efficacious dose compared with placebo given the observed data was 0·9966 for cannabidiol 400 mg and 0·9247 for cannabidiol 800 mg. Compared with placebo, cannabidiol 400 mg decreased THC-COOH:creatinine ratio by −94·21 ng/mL (95% interval estimate −161·83 to −35·56) and increased abstinence from cannabis by 0·48 days per week (0·15 to 0·82). Compared with placebo, cannabidiol 800 mg decreased THC-COOH:creatinine ratio by −72·02 ng/mL (−135·47 to −19·52) and increased abstinence from cannabis by 0·27 days per week (−0·09 to 0·64). Cannabidiol was well tolerated, with no severe adverse events recorded, and 77 (94%) of 82 participants completed treatment. Interpretation In the first randomised clinical trial of cannabidiol for cannabis use disorder, cannabidiol 400 mg and 800 mg were safe and more efficacious than placebo at reducing cannabis use.Medical Research Council (MRC

Cross-sectional study comparing cognitive function in treatment responsive versus treatment non-responsive schizophrenia: evidence from the STRATA study

Background 70%–84% of individuals with antipsychotic treatment resistance show non-response from the first episode. Emerging cross-sectional evidence comparing cognitive profiles in treatment resistant schizophrenia to treatment-responsive schizophrenia has indicated that verbal memory and language functions may be more impaired in treatment resistance. We sought to confirm this finding by comparing cognitive performance between antipsychotic non-responders (NR) and responders (R) using a brief cognitive battery for schizophrenia, with a primary focus on verbal tasks compared against other measures of cognition. Design Cross-sectional. Setting This cross-sectional study recruited antipsychotic treatment R and antipsychotic NR across four UK sites. Cognitive performance was assessed using the Brief Assessment of Cognition in Schizophrenia (BACS). Participants One hundred and six participants aged 18–65 years with a diagnosis of schizophrenia or schizophreniform disorder were recruited according to their treatment response, with 52 NR and 54 R cases. Outcomes Composite and subscale scores of cognitive performance on the BACS. Group (R vs NR) differences in cognitive scores were investigated using univariable and multivariable linear regressions adjusted for age, gender and illness duration. Results Univariable regression models observed no significant differences between R and NR groups on any measure of the BACS, including verbal memory (ß=−1.99, 95% CI −6.63 to 2.66, p=0.398) and verbal fluency (ß=1.23, 95% CI −2.46 to 4.91, p=0.510). This pattern of findings was consistent in multivariable models. Conclusions The lack of group difference in cognition in our sample is likely due to a lack of clinical distinction between our groups. Future investigations should aim to use machine learning methods using longitudinal first episode samples to identify responder subtypes within schizophrenia, and how cognitive factors may interact within this